
Midatech Pharma plc MTP
Annual report 2024
added 03-21-2026
Midatech Pharma plc DPO Ratio 2011-2026 | MTP
Annual DPO Ratio Midatech Pharma plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 162 | 11.9 K | - | - | - | - |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.9 K | 162 | 6.04 K |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Verastem
VSTM
|
1.26 K | $ 5.04 | -4.73 % | $ 349 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
182 | - | - | $ 546 M | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Avid Bioservices
CDMO
|
62.3 | - | - | $ 789 M | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
35.1 | $ 12.41 | -11.1 % | $ 1.88 B | ||
|
Xenetic Biosciences
XBIO
|
1.84 K | $ 2.72 | -2.86 % | $ 4.63 M | ||
|
XBiotech
XBIT
|
1.26 K | $ 2.27 | -1.73 % | $ 69.2 M | ||
|
Xenon Pharmaceuticals
XENE
|
40.5 | $ 54.48 | -1.89 % | $ 4.24 B | ||
|
Xeris Pharmaceuticals
XERS
|
23 | $ 5.4 | -3.05 % | $ 866 M | ||
|
X4 Pharmaceuticals
XFOR
|
454 | $ 4.04 | -6.26 % | $ 171 M | ||
|
XOMA Corporation
XOMA
|
9.87 K | $ 30.17 | -1.18 % | $ 364 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
22nd Century Group
XXII
|
60.9 | $ 2.41 | -18.03 % | $ 444 K | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
Zai Lab Limited
ZLAB
|
232 | $ 18.0 | 2.8 % | $ 19.7 B | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
193 | $ 1.05 | -3.67 % | $ 21.5 M |